JL
James Woodruff Lillie (Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $1.4M of MPLT (49,719 sh across 5 lots, as filed), executed May 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Aug 3
Filed Aug 4
Median ADV $7.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
MPLTRecent filings
MPLTSALE
MapLight Therapeutics, Inc.
View filing →
$277K22,082 sh × $12.54
Exec Aug 3
Filed Aug 4 · 8:39 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $513K
13,928 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 9:45 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $1.4M
49,719 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET